Utility of 1,2‐o‐dilauryl‐rac‐glycero glutaric acid‐(6′‐methylresorufin)‐ester‐lipase for monitoring dogs with chronic pancreatitis

Abstract Background The utility of 1,2‐o‐dilauryl‐rac‐glycero glutaric acid‐(6′‐methylresorufin)‐ester‐(DGGR)‐lipase activity (DLA) in monitoring clinical progression of chronic pancreatitis (CP) in dogs is unknown. Objective To examine the association of DLA with clinical signs of CP, as assessed b...

Full description

Bibliographic Details
Main Authors: Sharon Kuzi, Dana Adlersberg, Itamar Aroch, Gilad Segev
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Journal of Veterinary Internal Medicine
Subjects:
Online Access:https://doi.org/10.1111/jvim.16638
_version_ 1797856217690800128
author Sharon Kuzi
Dana Adlersberg
Itamar Aroch
Gilad Segev
author_facet Sharon Kuzi
Dana Adlersberg
Itamar Aroch
Gilad Segev
author_sort Sharon Kuzi
collection DOAJ
description Abstract Background The utility of 1,2‐o‐dilauryl‐rac‐glycero glutaric acid‐(6′‐methylresorufin)‐ester‐(DGGR)‐lipase activity (DLA) in monitoring clinical progression of chronic pancreatitis (CP) in dogs is unknown. Objective To examine the association of DLA with clinical signs of CP, as assessed by a CP clinical severity score (CPCSS). Animals: Twenty‐four dogs. Methods This is a retrospective study. Chronic pancreatitis was diagnosed based on clinical signs and DLA > 250 U/L and monitored using CPCSS and DLA. Results The study included 134 visits (median, 10 visits/dog; range, 2‐11). Mild‐moderate (CPCSS, 0‐3) and severe (CPCSS, ≥4) disease were documented in 94 (70%) and 40 (30%) visits, respectively. In emergency visits (n = 44; 33%) CPCSS (median, 5; range, 0‐15) and DLA (median, 534 U/L; range, 63‐7133) were higher (P < .001 and P = .003, respectively) than in scheduled ones (n = 90; 67%; median, 1; range, 0‐6 and median, 384 U/L; range, 49‐3747, respectively). DGGR‐lipase activity was associated (P = .009) with the CPCSS, with a lower activity documented in mild‐moderate CPCSS (median 391 U/L; range, 49‐3747), compared to severe score (median, 558 U/L; range, 63‐7133). DGGR‐lipase activity was significantly, but weakly, correlated with CPSS (r = 0.233, P = .007). DGGR‐lipase activity inefficiently discriminated mild‐moderate vs severe CP (area under the receiver operator characteristics curve, 0.64; 95% confidence interval, 0.53‐0.75; P = .012), with DLA cutoff of 428 U/L corresponding to sensitivity of 65% and specificity of 63%. Conclusions and Clinical Importance Increased DLA is associated with emergency revisits in dogs with CP, possibly reflecting acute flare‐ups. DGGR‐lipase activity was associated with the CPCSS over the follow‐ups but could not differentiate disease severity.
first_indexed 2024-04-09T20:36:50Z
format Article
id doaj.art-774c4efced754709816ec83c1abb87dc
institution Directory Open Access Journal
issn 0891-6640
1939-1676
language English
last_indexed 2024-04-09T20:36:50Z
publishDate 2023-03-01
publisher Wiley
record_format Article
series Journal of Veterinary Internal Medicine
spelling doaj.art-774c4efced754709816ec83c1abb87dc2023-03-30T07:47:05ZengWileyJournal of Veterinary Internal Medicine0891-66401939-16762023-03-0137243744510.1111/jvim.16638Utility of 1,2‐o‐dilauryl‐rac‐glycero glutaric acid‐(6′‐methylresorufin)‐ester‐lipase for monitoring dogs with chronic pancreatitisSharon Kuzi0Dana Adlersberg1Itamar Aroch2Gilad Segev3Department of Small Animals Internal Medicine Hebrew University Veterinary Teaching Hospital and Koret School of Veterinary Medicine, Hebrew University of Jerusalem Rehovot 761001 IsraelDepartment of Small Animals Internal Medicine Hebrew University Veterinary Teaching Hospital and Koret School of Veterinary Medicine, Hebrew University of Jerusalem Rehovot 761001 IsraelDepartment of Small Animals Internal Medicine Hebrew University Veterinary Teaching Hospital and Koret School of Veterinary Medicine, Hebrew University of Jerusalem Rehovot 761001 IsraelDepartment of Small Animals Internal Medicine Hebrew University Veterinary Teaching Hospital and Koret School of Veterinary Medicine, Hebrew University of Jerusalem Rehovot 761001 IsraelAbstract Background The utility of 1,2‐o‐dilauryl‐rac‐glycero glutaric acid‐(6′‐methylresorufin)‐ester‐(DGGR)‐lipase activity (DLA) in monitoring clinical progression of chronic pancreatitis (CP) in dogs is unknown. Objective To examine the association of DLA with clinical signs of CP, as assessed by a CP clinical severity score (CPCSS). Animals: Twenty‐four dogs. Methods This is a retrospective study. Chronic pancreatitis was diagnosed based on clinical signs and DLA > 250 U/L and monitored using CPCSS and DLA. Results The study included 134 visits (median, 10 visits/dog; range, 2‐11). Mild‐moderate (CPCSS, 0‐3) and severe (CPCSS, ≥4) disease were documented in 94 (70%) and 40 (30%) visits, respectively. In emergency visits (n = 44; 33%) CPCSS (median, 5; range, 0‐15) and DLA (median, 534 U/L; range, 63‐7133) were higher (P < .001 and P = .003, respectively) than in scheduled ones (n = 90; 67%; median, 1; range, 0‐6 and median, 384 U/L; range, 49‐3747, respectively). DGGR‐lipase activity was associated (P = .009) with the CPCSS, with a lower activity documented in mild‐moderate CPCSS (median 391 U/L; range, 49‐3747), compared to severe score (median, 558 U/L; range, 63‐7133). DGGR‐lipase activity was significantly, but weakly, correlated with CPSS (r = 0.233, P = .007). DGGR‐lipase activity inefficiently discriminated mild‐moderate vs severe CP (area under the receiver operator characteristics curve, 0.64; 95% confidence interval, 0.53‐0.75; P = .012), with DLA cutoff of 428 U/L corresponding to sensitivity of 65% and specificity of 63%. Conclusions and Clinical Importance Increased DLA is associated with emergency revisits in dogs with CP, possibly reflecting acute flare‐ups. DGGR‐lipase activity was associated with the CPCSS over the follow‐ups but could not differentiate disease severity.https://doi.org/10.1111/jvim.16638abdominal painacute on chronic pancreatitiscanineDGGR‐lipase
spellingShingle Sharon Kuzi
Dana Adlersberg
Itamar Aroch
Gilad Segev
Utility of 1,2‐o‐dilauryl‐rac‐glycero glutaric acid‐(6′‐methylresorufin)‐ester‐lipase for monitoring dogs with chronic pancreatitis
Journal of Veterinary Internal Medicine
abdominal pain
acute on chronic pancreatitis
canine
DGGR‐lipase
title Utility of 1,2‐o‐dilauryl‐rac‐glycero glutaric acid‐(6′‐methylresorufin)‐ester‐lipase for monitoring dogs with chronic pancreatitis
title_full Utility of 1,2‐o‐dilauryl‐rac‐glycero glutaric acid‐(6′‐methylresorufin)‐ester‐lipase for monitoring dogs with chronic pancreatitis
title_fullStr Utility of 1,2‐o‐dilauryl‐rac‐glycero glutaric acid‐(6′‐methylresorufin)‐ester‐lipase for monitoring dogs with chronic pancreatitis
title_full_unstemmed Utility of 1,2‐o‐dilauryl‐rac‐glycero glutaric acid‐(6′‐methylresorufin)‐ester‐lipase for monitoring dogs with chronic pancreatitis
title_short Utility of 1,2‐o‐dilauryl‐rac‐glycero glutaric acid‐(6′‐methylresorufin)‐ester‐lipase for monitoring dogs with chronic pancreatitis
title_sort utility of 1 2 o dilauryl rac glycero glutaric acid 6 methylresorufin ester lipase for monitoring dogs with chronic pancreatitis
topic abdominal pain
acute on chronic pancreatitis
canine
DGGR‐lipase
url https://doi.org/10.1111/jvim.16638
work_keys_str_mv AT sharonkuzi utilityof12odilaurylracglyceroglutaricacid6methylresorufinesterlipaseformonitoringdogswithchronicpancreatitis
AT danaadlersberg utilityof12odilaurylracglyceroglutaricacid6methylresorufinesterlipaseformonitoringdogswithchronicpancreatitis
AT itamararoch utilityof12odilaurylracglyceroglutaricacid6methylresorufinesterlipaseformonitoringdogswithchronicpancreatitis
AT giladsegev utilityof12odilaurylracglyceroglutaricacid6methylresorufinesterlipaseformonitoringdogswithchronicpancreatitis